X4 Pharmaceuticals Statistics
Total Valuation
XFOR has a market cap or net worth of $321.24 million. The enterprise value is $190.49 million.
| Market Cap | 321.24M |
| Enterprise Value | 190.49M |
Important Dates
The next estimated earnings date is Wednesday, November 4, 2026, before market open.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XFOR has 99.15 million shares outstanding. The number of shares has increased by 1,374.07% in one year.
| Current Share Class | 99.15M |
| Shares Outstanding | 99.15M |
| Shares Change (YoY) | +1,374.07% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.69% |
| Owned by Institutions (%) | 62.04% |
| Float | 57.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.27 |
| Forward PS | 33.53 |
| PB Ratio | 2.00 |
| P/TBV Ratio | 2.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.30, with a Debt / Equity ratio of 0.50.
| Current Ratio | 11.30 |
| Quick Ratio | 10.84 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.23 |
Financial Efficiency
Return on equity (ROE) is -113.08% and return on invested capital (ROIC) is -439.71%.
| Return on Equity (ROE) | -113.08% |
| Return on Assets (ROA) | -28.15% |
| Return on Invested Capital (ROIC) | -439.71% |
| Return on Capital Employed (ROCE) | -34.52% |
| Weighted Average Cost of Capital (WACC) | 7.20% |
| Revenue Per Employee | $352,156 |
| Profits Per Employee | -$2.00M |
| Employee Count | 45 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 0.68 |
Taxes
| Income Tax | -28,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.52% in the last 52 weeks. The beta is 0.46, so XFOR's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +4.52% |
| 50-Day Moving Average | 3.41 |
| 200-Day Moving Average | 3.82 |
| Relative Strength Index (RSI) | 57.00 |
| Average Volume (20 Days) | 733,887 |
Short Selling Information
The latest short interest is 7.59 million, so 7.66% of the outstanding shares have been sold short.
| Short Interest | 7.59M |
| Short Previous Month | 8.24M |
| Short % of Shares Out | 7.66% |
| Short % of Float | 13.26% |
| Short Ratio (days to cover) | 6.42 |
Income Statement
In the last 12 months, XFOR had revenue of $15.85 million and -$90.14 million in losses. Loss per share was -$0.89.
| Revenue | 15.85M |
| Gross Profit | 12.92M |
| Operating Income | -80.67M |
| Pretax Income | -90.17M |
| Net Income | -90.14M |
| EBITDA | -79.00M |
| EBIT | -80.67M |
| Loss Per Share | -$0.89 |
Balance Sheet
The company has $207.97 million in cash and $77.22 million in debt, with a net cash position of $130.75 million or $1.32 per share.
| Cash & Cash Equivalents | 207.97M |
| Total Debt | 77.22M |
| Net Cash | 130.75M |
| Net Cash Per Share | $1.32 |
| Equity (Book Value) | 155.45M |
| Book Value Per Share | 1.62 |
| Working Capital | 199.49M |
Cash Flow
| Operating Cash Flow | -83.74M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.67M |
| Net Borrowing | n/a |
| Free Cash Flow | -83.74M |
| FCF Per Share | -$0.84 |
Margins
| Gross Margin | 81.51% |
| Operating Margin | -509.06% |
| Pretax Margin | -568.98% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
XFOR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1,374.07% |
| Shareholder Yield | -1,374.07% |
| Earnings Yield | -27.37% |
| FCF Yield | -26.07% |
Analyst Forecast
The average price target for XFOR is $11.60, which is 258.03% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.60 |
| Price Target Difference | 258.03% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 1.16% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 28, 2025. It was a reverse split with a ratio of 1:30.
| Last Split Date | Apr 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
XFOR has an Altman Z-Score of -1.99 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.99 |
| Piotroski F-Score | 2 |